Remdesivir Implementation Panel

Remdesivir (Veklury) is authorized by Health Canada to treat patients with severe COVID-19 symptoms who have pneumonia and need extra oxygen to help them breathe. The drug is administered intravenously and is only to be used in health care facilities where patients can be closely monitored. CADTH is convening an implementation panel of clinical specialists […]

Virtual Waiting Rooms

The “CADTH Work in Progress” page on the CADTH COVID-19 website is updated regularly. Please be advised that there may be overlap between when a new report is posted online and when the section is updated.